Loading company…
Radar Therapeutics develops precision RNA therapies and gene detection technology for cancer treatment.
Founded in 2022 and based in Berkeley, Radar Therapeutics develops precision RNA-based therapies, primarily for oncology. Its technology detects genes to target specific cells in cancer treatment. The company was co-founded by Eerik Kaseniit and Sophia Lugo.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in